BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26101161)

  • 1. Molecular basis and clinical significance of genetic aberrations in B-cell precursor acute lymphoblastic leukemia.
    Ghazavi F; Lammens T; Van Roy N; Poppe B; Speleman F; Benoit Y; Van Vlierberghe P; De Moerloose B
    Exp Hematol; 2015 Aug; 43(8):640-53. PubMed ID: 26101161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interphase-FISH screening for eight common rearrangements in pediatric B-cell precursor acute lymphoblastic leukemia.
    Hutspardol S; Pakakasama S; Kanta K; Nuntakarn L; Anurathapan U; Sirachainan N; Songdej D; Sawangpanich R; Tiyasirichokchai R; Rerkamnuaychoke B; Hongeng S
    Int J Lab Hematol; 2013 Aug; 35(4):406-15. PubMed ID: 23190578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia.
    Moorman AV
    Blood Rev; 2012 May; 26(3):123-35. PubMed ID: 22436535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia.
    Balatzenko G; Guenova M; Kalinova I; Belcheva M; Hristozova H; Kaleva V
    Cancer Genet; 2013 Mar; 206(3):97-101. PubMed ID: 23491079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD99 expression is strongly associated with clinical outcome in children with B-cell precursor acute lymphoblastic leukaemia.
    Chen D; Camponeschi A; Wu Q; Gerasimcik N; Li H; Shen X; Tan Y; Sjögren H; Nordlund J; Lönnerholm G; Abrahamsson J; Fogelstrand L; Mårtensson IL
    Br J Haematol; 2019 Feb; 184(3):418-423. PubMed ID: 30484860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia.
    Steeghs EMP; Bakker M; Hoogkamer AQ; Boer JM; Hartman QJ; Stalpers F; Escherich G; de Haas V; de Groot-Kruseman HA; Pieters R; den Boer ML
    Sci Rep; 2018 Jan; 8(1):693. PubMed ID: 29330417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of acute lymphoblastic leukemia.
    Teitell MA; Pandolfi PP
    Annu Rev Pathol; 2009; 4():175-98. PubMed ID: 18783329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal karyotype CALLA-positive adult pre-B ALL: dismal outcome with chemotherapy for patients with loss/gain of ABL1 and/or BCR FISH signals.
    Abou Mourad YR; Bhargava R; Bruyère H; Gillian T; Barnett MJ; Forrest DL; Nevill TJ; Toze CL; Nantel SH; Shepherd JD
    Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):281-6. PubMed ID: 23098889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion.
    Langabeer SE; Haslam K; Kelly J; Leahy M; Vandenberghe E
    Acta Haematol; 2011; 126(4):214-5. PubMed ID: 21934295
    [No Abstract]   [Full Text] [Related]  

  • 11. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.
    Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
    Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New genetic abnormalities and treatment response in acute lymphoblastic leukemia.
    Meijerink JP; den Boer ML; Pieters R
    Semin Hematol; 2009 Jan; 46(1):16-23. PubMed ID: 19100364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New strategies in acute lymphoblastic leukemia: translating advances in genomics into clinical practice.
    Mullighan CG
    Clin Cancer Res; 2011 Feb; 17(3):396-400. PubMed ID: 21149616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemia.
    Fidyt K; Pastorczak A; Goral A; Szczygiel K; Fendler W; Muchowicz A; Bartlomiejczyk MA; Madzio J; Cyran J; Graczyk-Jarzynka A; Jansen E; Patkowska E; Lech-Maranda E; Pal D; Blair H; Burdzinska A; Pedzisz P; Glodkowska-Mrowka E; Demkow U; Gawle-Krawczyk K; Matysiak M; Winiarska M; Juszczynski P; Mlynarski W; Heidenreich O; Golab J; Firczuk M
    Mol Oncol; 2019 May; 13(5):1180-1195. PubMed ID: 30861284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia.
    Vendramini E; Giordan M; Giarin E; Michielotto B; Fazio G; Cazzaniga G; Biondi A; Silvestri D; Valsecchi MG; Muckenthaler MU; Kulozik AE; Gattei V; Izraeli S; Basso G; Te Kronnie G
    Oncotarget; 2017 Jun; 8(26):42398-42413. PubMed ID: 28415578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the molecular pathobiology of B-lymphoblastic leukemia.
    Zhou Y; You MJ; Young KH; Lin P; Lu G; Medeiros LJ; Bueso-Ramos CE
    Hum Pathol; 2012 Sep; 43(9):1347-62. PubMed ID: 22575265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of cell lines from B-cell precursor acute lymphoblastic leukemia.
    Zhang LQ; Downie PA; Goodell WR; McCabe NR; LeBeau MM; Morgan R; Sklar J; Raimondi SC; Miley D; Goldberg A
    Leukemia; 1993 Nov; 7(11):1865-74. PubMed ID: 8231254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia.
    Ivanov Öfverholm I; Tran AN; Olsson L; Zachariadis V; Heyman M; Rudd E; Syk Lundberg E; Nordenskjöld M; Johansson B; Nordgren A; Barbany G
    Leuk Lymphoma; 2016 Sep; 57(9):2161-70. PubMed ID: 27090575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABL deletion without associated BCR-ABL in precursor B-cell acute lymphoblastic leukemia.
    Lo A; Gu G; Liu M; Dev VG
    Leuk Res; 2009 Aug; 33(8):e98-103. PubMed ID: 19282030
    [No Abstract]   [Full Text] [Related]  

  • 20. Frequency of copy number abnormalities in common genes associated with B-cell precursor acute lymphoblastic leukemia cytogenetic subtypes in Brazilian children.
    Barbosa TC; Terra-Granado E; Quezado Magalhães IM; Neves GR; Gadelha A; Guedes Filho GE; Souza MS; Melaragno R; Emerenciano M; Pombo-de-Oliveira MS
    Cancer Genet; 2015 Oct; 208(10):492-501. PubMed ID: 26277549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.